Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2001;37:1164-1170

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lou, Y.-k.
Right arrow Articles by Whitworth, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lou, Y.-k.
Right arrow Articles by Whitworth, J. A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure
Related Collections
Right arrow Other hypertension
Right arrow Gene expression
Right arrow Gene regulation
Right arrow Hypertension - basic studies

(Hypertension. 2001;37:1164.)
© 2001 American Heart Association, Inc.


Scientific Contributions

Decreased Renal Expression of Nitric Oxide Synthase Isoforms in Adrenocorticotropin-Induced and Corticosterone-Induced Hypertension

Yi-kun Lou; Cheng Wen; Ming Li; David J. Adams; Min-xia Wang; Feng Yang; Brian J. Morris; Judith A. Whitworth

From the Department of Physiology and Institute for Biomedical Research (Y.L., D.J.A., B.J.M.), and Department of Pathology (F.Y), Basic & Clinical Genomics Laboratory, Department of Medicine (C.W., M.L., M.W.), St George Hospital, The University of Sydney; and The John Curtain School of Medical Research (J.A.W.), Australian National University, Canberra (Australia).

Correspondence to Judith A. Whitworth, The John Curtain School of Medical Research, Australian National University, PO Box 334, Canberra ACT 2601, Australia. E-mail Director{at}JCSMR.anu.edu.au

Abstract—Administration of adrenocorticotropic hormone (ACTH) leads to the development of hypertension. Because glucocorticoids can affect the nitric oxide system at several sites, the present study tested the hypothesis that nitric oxide synthase (NOS) expression may be altered in ACTH-induced and corticosterone-induced hypertension in the rat. This was addressed by measuring Nos1, Nos2, and Nos3 mRNA in the kidney, adrenal gland, heart, and hypothalamus of 16 ACTH-treated and 16 vehicle-treated rats as well as in 10 corticosterone-treated and 10 control rats. In addition, in situ hybridization and immunohistochemistry were used to confirm changes by detection of Nos in RNA and NOS protein in tissues. Systolic blood pressure of ACTH and corticosterone rats was elevated (165±6 and 162±11 mm Hg; P<0.001 versus control). Each Nos isoform mRNA was measured by reverse transcriptase-polymerase chain reaction technique. In ACTH rats, mRNA for Nos2 was reduced in renal cortex by 58±5% and in medulla by 68±7%; for Nos3, mRNA reductions of 59±6% and 51±11% were seen (P<0.001 after Hochberg correction for multiple comparisons). In corticosterone rats, Nos2 mRNA decreased in cortex by 68±5% and in medulla by 62±6%; Nos3 mRNA by 50±8% in cortex, and Nos1 by 29±7% in medulla (all P<0.001 after Hochberg correction). Reductions seen in kidney were supported by in situ hybridization and immunohistochemistry. Apart from a 62±2% decrease in Nos2 mRNA in adrenal of ACTH rats (corrected P<0.05), no significant changes were seen in the other nonrenal tissues for any isoform. In conclusion, we have shown for the first time that the physiological components of glucocorticoid action (ACTH and corticosterone) when given chronically in vivo reduce Nos2 and Nos3 expression in the kidney. Such changes are consistent with a role in hypertension for ACTH and corticosterone.


Key Words: immunohistochemistry • hybridization • RNA • nitric oxide • isoenzymes • reverse transcriptase–polymerase chain reaction




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
E. Cediel, D. Sanz-Rosa, M. P. Oubina, N. de las Heras, F. R. G. Pacheco, O. Vegazo, J. Jimenez, V. Cachofeiro, and V. Lahera
Effect of AT1 receptor blockade on hepatic redox status in SHR: possible relevance for endothelial function?
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2003; 285(3): R674 - R681.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. P.F. Chin-Dusting, B. A. Ahlers, D. M. Kaye, J. J. Kelly, and J. A. Whitworth
L-Arginine Transport in Humans With Cortisol-Induced Hypertension
Hypertension, June 1, 2003; 41(6): 1336 - 1340.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. Y.H. Chan, L.-L. Wang, Y.-M. Chao, and S. H.H. Chan
Downregulation of Basal iNOS at the Rostral Ventrolateral Medulla Is Innate in SHR
Hypertension, March 1, 2003; 41(3): 563 - 570.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. Nishimoto, T. Tomida, H. Matsui, T. Ito, and K. Okumura
Decrease in Renal Medullary Endothelial Nitric Oxide Synthase of Fructose-Fed, Salt-Sensitive Hypertensive Rats
Hypertension, August 1, 2002; 40(2): 190 - 194.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
B. T. Alexander, K. Cockrell, F. D. Cline, and J. P. Granger
Inducible Nitric Oxide Synthase Inhibition Attenuates Renal Hemodynamics During Pregnancy
Hypertension, February 1, 2002; 39(2): 586 - 590.
[Abstract] [Full Text] [PDF]